Search
Inhibikase Therapeutics Inc
IKTAdd to Watchlist
1.990USD
+0.050+2.58%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
262.74MMarket Cap
LossP/E TTM
Inhibikase Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.49
57.70%
Analyst Rating
BUY
2026-07-05
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its current assets were 180.11M, with a year-on-year change of 82.94.
What are the total assets of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its total assets of Inhibikase Therapeutics Inc were 181.20M, with a year-on-year change of 83.78.
What are the total liabilities of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its total liabilities of Inhibikase Therapeutics Inc were 8.30M, with a year-on-year change of 122.33.
What is the total equity of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its total equity of Inhibikase Therapeutics Inc was 172.90M, with a year-on-year change of 82.26.
What is the net investment of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its net investment of Inhibikase Therapeutics Inc was 2.05M, with a year-on-year change of 105.55.
What is the net financing of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its net financing of Inhibikase Therapeutics Inc was 108.46M, with a year-on-year change of 4.82.
What is the Earnings Per Share (EPS) of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.49, with a year-on-year change of 57.70.
What is the Return on Equity (ROE) of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -36.05, with a year-on-year change of 30.68.
What is the Return on Assets (ROA) of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -34.49, with a year-on-year change of 29.11.
What is the operating profit of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its operating profit was -45.95M, with a year-on-year change of -60.72.